ObvioHealth and SPRIM PRO Launch Integrated Digital Patient Monitoring for High-Risk Therapies
- ObvioHealth and SPRIM PRO announced a combined digital patient monitoring and clinical support solution targeting REMS programs, specialty medicines, and advanced biologics requiring enhanced oversight.
- The offering integrates ObvioHealth's ObvioGo® digital platform with SPRIM PRO's 25+ years of clinical research and remote patient monitoring expertise to support sponsors from late-stage development through commercialization.
- The solution enables hybrid monitoring strategies combining digital symptom reporting, telehealth, configurable escalation pathways, and real-time clinical oversight to extend oversight beyond traditional care settings.
Operational Impact
CRO directors evaluating patient monitoring and REMS support capabilities can now assess a unified ObvioHealth–SPRIM PRO offering that consolidates digital platform, clinical operations, and remote patient engagement into a single vendor relationship for late-stage and commercial programs.
Source: PR Newswire pharma category RSS